391 related articles for article (PubMed ID: 17608397)
1. Novel semisynthetic derivative of antibiotic Eremomycin active against drug-resistant gram-positive pathogens including Bacillus anthracis.
Maples KR; Wheeler C; Ip E; Plattner JJ; Chu D; Zhang YK; Preobrazhenskaya MN; Printsevskaya SS; Solovieva SE; Olsufyeva EN; Heine H; Lovchik J; Lyons CR
J Med Chem; 2007 Jul; 50(15):3681-5. PubMed ID: 17608397
[TBL] [Abstract][Full Text] [Related]
2. Eremomycin pyrrolidide: a novel semisynthetic glycopeptide with improved chemotherapeutic properties.
Olsufyeva EN; Shchekotikhin AE; Bychkova EN; Pereverzeva ER; Treshalin ID; Mirchink EP; Isakova EB; Chernobrovkin MG; Kozlov RS; Dekhnich AV; Preobrazhenskaya MN
Drug Des Devel Ther; 2018; 12():2875-2885. PubMed ID: 30237697
[TBL] [Abstract][Full Text] [Related]
3. N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin. II. Antibacterial activity of N'-(alpha-aminoacyl)- and N'-alpha-(N-alkylamino)acyl derivatives of vancomycin and eremomycin.
Plattner JJ; Chu D; Mirchink EP; Isakova EB; Preobrazhenskaya MN; Olsufyeva EN; Miroshnikova OV; Printsevskaya SS
J Antibiot (Tokyo); 2007 Apr; 60(4):245-50. PubMed ID: 17456974
[TBL] [Abstract][Full Text] [Related]
4. Role of the glycopeptide framework in the antibacterial activity of hydrophobic derivatives of glycopeptide antibiotics.
Printsevskaya SS; Pavlov AY; Olsufyeva EN; Mirchink EP; Preobrazhenskaya MN
J Med Chem; 2003 Mar; 46(7):1204-9. PubMed ID: 12646030
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antibacterial activity of N4-mono alkyl derivatives of novel glycopeptide LYV07ww01.
Shao C; Zhou W; Zhang S; Wei W; Ruan L; Jin Y; Sun X; Huang Y
Bioorg Med Chem Lett; 2011 Nov; 21(22):6732-8. PubMed ID: 21978682
[TBL] [Abstract][Full Text] [Related]
6. A multivalent approach to drug discovery for novel antibiotics.
Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres.
Gales AC; Sader HS; Jones RN
Clin Microbiol Infect; 2005 Feb; 11(2):95-100. PubMed ID: 15679482
[TBL] [Abstract][Full Text] [Related]
8. Water-soluble pleuromutilin derivative with excellent in vitro and in vivo antibacterial activity against gram-positive pathogens.
Hirokawa Y; Kinoshita H; Tanaka T; Nakata K; Kitadai N; Fujimoto K; Kashimoto S; Kojima T; Kato S
J Med Chem; 2008 Apr; 51(7):1991-4. PubMed ID: 18330977
[TBL] [Abstract][Full Text] [Related]
9. Glycopeptides: Update on an old successful antibiotic class.
Pace JL; Yang G
Biochem Pharmacol; 2006 Mar; 71(7):968-80. PubMed ID: 16412985
[TBL] [Abstract][Full Text] [Related]
10. [New derivatives of eremomycin containing (15)n or f atoms for NMR study].
Solov'eva SE; Printsevskaia SS; Olsuf'eva EN; Batta G; Preobrazhenskaia MN
Bioorg Khim; 2008; 34(6):831-9. PubMed ID: 19088759
[TBL] [Abstract][Full Text] [Related]
11. Exploring the positional attachment of glycopeptide/beta-lactam heterodimers.
Long DD; Aggen JB; Chinn J; Choi SK; Christensen BG; Fatheree PR; Green D; Hegde SS; Judice JK; Kaniga K; Krause KM; Leadbetter M; Linsell MS; Marquess DG; Moran EJ; Nodwell MB; Pace JL; Trapp SG; Turner SD
J Antibiot (Tokyo); 2008 Oct; 61(10):603-14. PubMed ID: 19168974
[TBL] [Abstract][Full Text] [Related]
12. DNA binding ligands targeting drug-resistant bacteria: structure, activity, and pharmacology.
Kaizerman JA; Gross MI; Ge Y; White S; Hu W; Duan JX; Baird EE; Johnson KW; Tanaka RD; Moser HE; Bürli RW
J Med Chem; 2003 Aug; 46(18):3914-29. PubMed ID: 12930152
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the in vitro activity of novel lipoglycopeptide antibiotics.
Arhin FF; Belley A; McKay GA; Moeck G
Curr Protoc Microbiol; 2010 Feb; Chapter 17():Unit17.1. PubMed ID: 20131224
[TBL] [Abstract][Full Text] [Related]
14. N-substituted 3-acetyltetramic acid derivatives as antibacterial agents.
Yendapally R; Hurdle JG; Carson EI; Lee RB; Lee RE
J Med Chem; 2008 Mar; 51(5):1487-91. PubMed ID: 18281930
[TBL] [Abstract][Full Text] [Related]
15. Identification of phenylisoxazolines as novel and viable antibacterial agents active against Gram-positive pathogens.
Barbachyn MR; Cleek GJ; Dolak LA; Garmon SA; Morris J; Seest EP; Thomas RC; Toops DS; Watt W; Wishka DG; Ford CW; Zurenko GE; Hamel JC; Schaadt RD; Stapert D; Yagi BH; Adams WJ; Friis JM; Slatter JG; Sams JP; Oien NL; Zaya MJ; Wienkers LC; Wynalda MA
J Med Chem; 2003 Jan; 46(2):284-302. PubMed ID: 12519066
[TBL] [Abstract][Full Text] [Related]
16. Pyrrolobenzodiazepine dimers: novel sequence-selective, DNA-interactive, cross-linking agents with activity against Gram-positive bacteria.
Hadjivassileva T; Thurston DE; Taylor PW
J Antimicrob Chemother; 2005 Sep; 56(3):513-8. PubMed ID: 16024592
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative.
Draghi DC; Benton BM; Krause KM; Thornsberry C; Pillar C; Sahm DF
J Antimicrob Chemother; 2008 Jul; 62(1):116-21. PubMed ID: 18424792
[TBL] [Abstract][Full Text] [Related]
18. N-thiolated 2-oxazolidinones: a new family of antibacterial agents for methicillin-resistant Staphylococcus aureus and Bacillus anthracis.
Mishra RK; Revell KD; Coates CM; Turos E; Dickey S; Lim DV
Bioorg Med Chem Lett; 2006 Apr; 16(8):2081-3. PubMed ID: 16464583
[TBL] [Abstract][Full Text] [Related]
19. Mannopeptimycins, a novel class of glycopeptide antibiotics active against gram-positive bacteria.
He H
Appl Microbiol Biotechnol; 2005 Jun; 67(4):444-52. PubMed ID: 15702316
[TBL] [Abstract][Full Text] [Related]
20. Semisynthetic glycopeptides: chemistry, structure-activity relationships and prospects.
Ciabatti R; Malabarba A
Farmaco; 1997 May; 52(5):313-21. PubMed ID: 9274002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
